Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT02626793
Eligibility Criteria:
Inclusion Criteria:
* The decision for a therapy with Apremilast was made before enrolment and independent of this study.
* Patient ≥ 18 years of age
* Diagnosis of moderate to severe plaque psoriasis
* Inadequate response or intolerance to a previous systemic treatment, or contraindication for systemic therapies.
* Written informed consent by the patient for data recording, statistical analysis, filing and forwarding of the data
Exclusion Criteria:
* Pregnancy
* Hypersensitivity to apremilast or any of the excipients of the film-coated tablet
* Other criteria according to the Summary of product characteristics (SmPC).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02626793
Study Brief:
Protocol Section:
NCT02626793